JOHN MARAGANORE - 13 Aug 2021 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role
Chief Executive Officer, Director
Signature
By: /s/ Mary Beth DeLena, Attorney-in-Fact For: John M. Maraganore
Issuer symbol
ALNY
Transactions as of
13 Aug 2021
Net transactions value
-$6,546,945
Form type
4
Filing time
16 Aug 2021, 16:38:54 UTC
Previous filing
02 Jun 2021
Next filing
08 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNY Common Stock Options Exercise $241,251 +33,979 +16% $7.10* 248,744 13 Aug 2021 Direct F1
transaction ALNY Common Stock Sale $483,367 -2,441 -0.98% $198.02 246,303 13 Aug 2021 Direct F1, F2
transaction ALNY Common Stock Sale $827,549 -4,160 -1.7% $198.93 242,143 13 Aug 2021 Direct F1, F3
transaction ALNY Common Stock Sale $4,665,333 -23,336 -9.6% $199.92 218,807 13 Aug 2021 Direct F1, F4
transaction ALNY Common Stock Sale $768,816 -3,828 -1.7% $200.84 214,979 13 Aug 2021 Direct F1, F5
transaction ALNY Common Stock Sale $43,132 -214 -0.1% $201.55 214,765 13 Aug 2021 Direct F1
holding ALNY Common Stock 3,133 13 Aug 2021 by Managed Account F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNY Stock Option (right to buy) Options Exercise $0 -33,979 -50% $0.000000 33,978 13 Aug 2021 Common Stock 33,979 $7.10 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2020. The 33,979 options exercised and sold by the reporting person were due to expire on November 30, 2021.
F2 Sale prices ranged from $197.44 to $198.44.
F3 Sale prices ranged from $198.45 to $199.44.
F4 Sale prices ranged from $199.46 to $200.45.
F5 Sale prices ranged from $200.48 to $201.43.
F6 Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
F7 The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.